CVE-2025-3423

IBM Aspera Faspex 5 cross-site scripting

At a glance

Severity: MEDIUM 5.4
EPSS: EPSS 0.28 % · percentile 21 (2026-10-27)
State: PUBLISHED
Published: 2025-04-13
Updated: 2025-09-01
Assigner: ibm
NVD status: Analyzed

Description

IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Scores

Version	Score	Vector	Scored by
CVSS 3.1	MEDIUM 5.4	CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N	ibm
CVSS 3.1	MEDIUM 5.4	CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N	NVD · psirt@us.ibm.com (Secondary)

Weaknesses (CWE)

CWE-79

European references

ENISA EUVD · EUVD-2025-10850
GCVE · GCVE-0-2025-3423

Affected configurations (NVD CPE)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:* ≥ 5.0.0 < 5.0.12

Affected products

Product	Versions
IBM · Aspera Faspex	affected 5.0.0 ≤ 5.0.11

References

https://www.ibm.com/support/pages/node/7230757

Sources

Source	Licence
CVE List (CVEProject cvelistV5)	CVE Program Terms of Use
EPSS (FIRST.org)	FIRST — attribution requested
ENISA EUVD	ENISA — reproduction authorised, source acknowledged
NVD (NIST) via fkie-cad/nvd-json-data-feeds	Public domain — this product uses data from the NVD API but is not endorsed or certified by the NVD